Ogita K, Ohkawara A, Suzuki T, Ohgaki T, Uchida S, Meguri H, Yoneda Y
Department of Pharmacology, Setsunan University, Osaka, Japan.
Neurochem Int. 1992 Jul;21(1):135-47. doi: 10.1016/0197-0186(92)90076-4.
The effects of a cerebral anti-ischemic drug ifenprodil on the receptor ionophore complex of an N-methyl-D-aspartate (NMDA)-sensitive subclass of central excitatory amino acid receptors were examined using 3H-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10- imine (MK-801) binding in rat brain synaptic membrane preparations as a biochemical measure. The binding in membrane preparations not extensively washed was markedly inhibited not only by competitive NMDA antagonists such as (+/-)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic, D-2-amino-5-phosphonovaleric and D-2-amino-7-phosphonoheptanoic acids, but also by competitive antagonists at the strychnine-insensitive glycine (Gly) site including 7-chlorokynurenic acid and 6,7-dichloroquinoxaline-2,3-dione. Among several proposed ligands for alpha-adrenergic receptors tested, ifenprodil most potently inhibited the binding in these membrane preparations due to a decrease in the density of the binding sites without significantly affecting the affinity. Ifenprodil also inhibited the binding of [3H]N-[1-(2-thienyl)cyclohexyl]piperidine as well as of [3H]MK-801 to open NMDA channels in a concentration-dependent manner at concentrations above 10 nM in membrane preparations extensively washed but not treated by a detergent, with a Hill coefficient of less than unity. Further treatment of extensively washed membrane preparations with a low concentration of Triton X-100 resulted in an almost complete abolition of [3H]MK-801 binding, and the binding was restored to the level found in membrane preparations not extensively washed following the addition of both L-glutamic acid (Glu) and Gly. Ifenprodil was effective in inhibiting [3H]MK-801 binding via reducing both initial association and dissociation rates in Triton-treated membrane preparations, irrespective of the presence of Glu and Gly added. The binding in Triton-treated membrane preparations was additionally potentiated by the polyamine spermidine in a concentration-dependent manner at concentrations above 10 microM in the presence of both Glu and Gly at maximally effective concentrations. Ifenprodil invariably diminished the abilities of these three stimulants to potentiate [3H]MK-801 binding at concentrations over 1 microM in a manner that the maximal responses each were reduced. These results suggest that ifenprodil does not interfere with the NMDA receptor complex as a specific isosteric antagonist at the polyamine domain in contrast to the prevailing view.
使用3H-5-甲基-10,11-二氢-5H-二苯并[a,d]环庚烯-5,10-亚胺(MK-801)与大鼠脑突触膜制剂的结合作为生化指标,研究了脑缺血药物艾芬地尔对中枢兴奋性氨基酸受体的N-甲基-D-天冬氨酸(NMDA)敏感亚类的受体离子通道复合物的影响。在未充分洗涤的膜制剂中,结合不仅被竞争性NMDA拮抗剂如(+/-)-3-(2-羧基哌嗪-4-基)丙基-1-膦酸、D-2-氨基-5-膦酸戊酸和D-2-氨基-7-膦酸庚酸显著抑制,还被士的宁不敏感甘氨酸(Gly)位点的竞争性拮抗剂如7-氯犬尿氨酸和6,7-二氯喹喔啉-2,3-二酮抑制。在测试的几种拟议的α-肾上腺素能受体配体中,艾芬地尔由于结合位点密度降低而最有效地抑制了这些膜制剂中的结合,而对亲和力没有显著影响。艾芬地尔还以浓度依赖的方式抑制[3H]N-[1-(2-噻吩基)环己基]哌啶以及[3H]MK-801在充分洗涤但未用去污剂处理的膜制剂中打开NMDA通道,希尔系数小于1,浓度高于10 nM。用低浓度的 Triton X-100 进一步处理充分洗涤的膜制剂,导致[3H]MK-801 结合几乎完全消失,在添加 L-谷氨酸(Glu)和 Gly 后,结合恢复到未充分洗涤的膜制剂中的水平。艾芬地尔在 Triton 处理的膜制剂中通过降低初始结合和解离速率有效抑制[3H]MK-801 结合,而与添加的 Glu 和 Gly 的存在无关。在最大有效浓度的 Glu 和 Gly 存在下,多胺亚精胺在浓度高于 10 μM 时以浓度依赖的方式额外增强了 Triton 处理的膜制剂中的结合。艾芬地尔在浓度超过 1 μM 时总是以降低各自最大反应的方式降低这三种刺激物增强[3H]MK-801 结合的能力。这些结果表明,与普遍观点相反,艾芬地尔作为多胺结构域的特异性等排拮抗剂并不干扰 NMDA 受体复合物。